Literature DB >> 24741088

Within-host whole-genome deep sequencing and diversity analysis of human respiratory syncytial virus infection reveals dynamics of genomic diversity in the absence and presence of immune pressure.

Yonatan H Grad1, Ruchi Newman2, Michael Zody2, Xiao Yang2, Ryan Murphy3, James Qu2, Christine M Malboeuf2, Joshua Z Levin2, Marc Lipsitch4, John DeVincenzo5.   

Abstract

UNLABELLED: Human respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract disease in infants and young children and an important respiratory pathogen in the elderly and immunocompromised. While population-wide molecular epidemiology studies have shown multiple cocirculating RSV genotypes and revealed antigenic and genetic change over successive seasons, little is known about the extent of viral diversity over the course of an individual infection, the origins of novel variants, or the effect of immune pressure on viral diversity and potential immune-escape mutations. To investigate viral population diversity in the presence and absence of selective immune pressures, we studied whole-genome deep sequencing of RSV in upper airway samples from an infant with severe combined immune deficiency syndrome and persistent RSV infection. The infection continued over several months before and after bone marrow transplant (BMT) from his RSV-immune father. RSV diversity was characterized in 26 samples obtained over 78 days. Diversity increased after engraftment, as defined by T-cell presence, and populations reflected variation mostly within the G protein, the major surface antigen. Minority populations with known palivizumab resistance mutations emerged after its administration. The viral population appeared to diversify in response to selective pressures, showing a statistically significant growth in diversity in the presence of pressure from immunity. Defining escape mutations and their dynamics will be useful in the design and application of novel therapeutics and vaccines. These data can contribute to future studies of the relationship between within-host and population-wide RSV phylodynamics. IMPORTANCE: Human RSV is an important cause of respiratory disease in infants, the elderly, and the immunocompromised. RSV circulating in a community appears to change season by season, but the amount of diversity generated during an individual infection and the impact of immunity on this viral diversity has been unclear. To address this question, we described within-host RSV diversity by whole-genome deep sequencing in a unique clinical case of an RSV-infected infant with severe combined immunodeficiency and effectively no adaptive immunity who then gained adaptive immunity after undergoing bone marrow transplantation. We found that viral diversity increased in the presence of adaptive immunity and was primarily within the G protein, the major surface antigen. These data will be useful in designing RSV treatments and vaccines and to help understand the relationship between the dynamics of viral diversification within individual hosts and the viral populations circulating in a community.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24741088      PMCID: PMC4054443          DOI: 10.1128/JVI.00038-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America.

Authors:  T C Peret; C B Hall; G W Hammond; P A Piedra; G A Storch; W M Sullender; C Tsou; L J Anderson
Journal:  J Infect Dis       Date:  2000-05-22       Impact factor: 5.226

2.  Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children.

Authors:  C B Hall; E E Walsh; K C Schnabel; C E Long; K M McConnochie; S W Hildreth; L J Anderson
Journal:  J Infect Dis       Date:  1990-12       Impact factor: 5.226

3.  WebLogo: a sequence logo generator.

Authors:  Gavin E Crooks; Gary Hon; John-Marc Chandonia; Steven E Brenner
Journal:  Genome Res       Date:  2004-06       Impact factor: 9.043

4.  Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo.

Authors:  M N Teng; S S Whitehead; P L Collins
Journal:  Virology       Date:  2001-10-25       Impact factor: 3.616

5.  Respiratory virus infections in pediatric hematopoietic stem cell transplantation.

Authors:  J Luján-Zilbermann; E Benaim; X Tong; D K Srivastava; C C Patrick; J P DeVincenzo
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

6.  Risk of primary infection and reinfection with respiratory syncytial virus.

Authors:  W P Glezen; L H Taber; A L Frank; J A Kasel
Journal:  Am J Dis Child       Date:  1986-06

7.  Quantitative effects of palivizumab and donor-derived T cells on chronic respiratory syncytial virus infection, lung disease, and fusion glycoprotein amino acid sequences in a patient before and after bone marrow transplantation.

Authors:  C M El Saleeby; J Suzich; M E Conley; J P DeVincenzo
Journal:  Clin Infect Dis       Date:  2004-07-01       Impact factor: 9.079

8.  Molecular evolution and circulation patterns of human respiratory syncytial virus subgroup a: positively selected sites in the attachment g glycoprotein.

Authors:  Kalina T Zlateva; Philippe Lemey; Anne-Mieke Vandamme; Marc Van Ranst
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 9.  Unifying the epidemiological and evolutionary dynamics of pathogens.

Authors:  Bryan T Grenfell; Oliver G Pybus; Julia R Gog; James L N Wood; Janet M Daly; Jenny A Mumford; Edward C Holmes
Journal:  Science       Date:  2004-01-16       Impact factor: 47.728

10.  V-Phaser 2: variant inference for viral populations.

Authors:  Xiao Yang; Patrick Charlebois; Alex Macalalad; Matthew R Henn; Michael C Zody
Journal:  BMC Genomics       Date:  2013-10-03       Impact factor: 3.969

View more
  22 in total

1.  Deep sequencing of RSV from an adult challenge study and from naturally infected infants reveals heterogeneous diversification dynamics.

Authors:  Jessica W Lau; Young-In Kim; Ryan Murphy; Ruchi Newman; Xiao Yang; Michael Zody; John DeVincenzo; Yonatan H Grad
Journal:  Virology       Date:  2017-08-03       Impact factor: 3.616

Review 2.  Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.

Authors:  Cameron Griffiths; Steven J Drews; David J Marchant
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor.

Authors:  Matthew Coates; Daniel Brookes; Young-In Kim; Heather Allen; Euan A F Fordyce; Elizabeth A Meals; Thomas Colley; Claire-Lise Ciana; Guillaume F Parra; Vladimir Sherbukhin; Jennifer A Stockwell; Jennifer C Thomas; S Fraser Hunt; Lauren Anderson-Dring; Stuart T Onions; Lindsey Cass; Peter J Murray; Kazuhiro Ito; Pete Strong; John P DeVincenzo; Garth Rapeport
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

4.  Limited Variation in BK Virus T-Cell Epitopes Revealed by Next-Generation Sequencing.

Authors:  Malaya K Sahoo; Susanna K Tan; Sharon F Chen; Beatrix Kapusinszky; Katherine R Concepcion; Lynn Kjelson; Kalyan Mallempati; Heidi M Farina; Marcelo Fernández-Viña; Dolly Tyan; Paul C Grimm; Matthew W Anderson; Waldo Concepcion; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2015-07-22       Impact factor: 5.948

5.  Prolonged viral replication and longitudinal viral dynamic differences among respiratory syncytial virus infected infants.

Authors:  Monica E Brint; Joshua M Hughes; Aditya Shah; Chelsea R Miller; Lisa G Harrison; Elizabeth A Meals; Jacqueline Blanch; Charlotte R Thompson; Stephania A Cormier; John P DeVincenzo
Journal:  Pediatr Res       Date:  2017-08-09       Impact factor: 3.756

6.  Direct whole-genome deep-sequencing of human respiratory syncytial virus A and B from Vietnamese children identifies distinct patterns of inter- and intra-host evolution.

Authors:  Lien Anh Ha Do; Andreas Wilm; H Rogier van Doorn; Ha Minh Lam; Shuzhen Sim; Rashmi Sukumaran; Anh Tuan Tran; Bach Hue Nguyen; Thi Thu Loan Tran; Quynh Huong Tran; Quoc Bao Vo; Nguyen Anh Tran Dac; Hong Nhien Trinh; Thi Thanh Hai Nguyen; Bao Tinh Le Binh; Khanh Le; Minh Tien Nguyen; Quang Tung Thai; Thanh Vu Vo; Ngoc Quang Minh Ngo; Thi Kim Huyen Dang; Ngoc Huong Cao; Thu Van Tran; Lu Viet Ho; Jeremy Farrar; Menno de Jong; Swaine Chen; Niranjan Nagarajan; Juliet E Bryant; Martin L Hibberd
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

7.  Deep sequencing analysis of viral infection and evolution allows rapid and detailed characterization of viral mutant spectrum.

Authors:  Ofer Isakov; Antonio V Bordería; David Golan; Amir Hamenahem; Gershon Celniker; Liron Yoffe; Hervé Blanc; Marco Vignuzzi; Noam Shomron
Journal:  Bioinformatics       Date:  2015-02-19       Impact factor: 6.937

8.  Relating plaque morphology to respiratory syncytial virus subgroup, viral load, and disease severity in children.

Authors:  Young-In Kim; Ryan Murphy; Sirshendu Majumdar; Lisa G Harrison; Jody Aitken; John P DeVincenzo
Journal:  Pediatr Res       Date:  2015-06-24       Impact factor: 3.756

9.  Respiratory syncytial virus human experimental infection model: provenance, production, and sequence of low-passaged memphis-37 challenge virus.

Authors:  Young-In Kim; John P DeVincenzo; Bart G Jones; Rajeev Rudraraju; Lisa Harrison; Rachel Meyers; Jeff Cehelsky; Rene Alvarez; Julia L Hurwitz
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

Review 10.  Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem.

Authors:  Ralph A Tripp; Ultan F Power; Peter J M Openshaw; Lawrence M Kauvar
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.